Cargando…
Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase
Since the outbreak of the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) has become a main target for antiviral therapeutics due to its essential role in viral replication and transcription. Thus, nucleoside analogs structurally re...
Autores principales: | Xu, Tiantian, Zhang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498173/ https://www.ncbi.nlm.nih.gov/pubmed/37711189 http://dx.doi.org/10.1016/j.csbj.2023.09.001 |
Ejemplares similares
-
Nucleoside Analogs That Inhibit SARS-CoV-2 Replication by Blocking Interaction of Virus Polymerase with RNA
por: Matyugina, Elena, et al.
Publicado: (2023) -
A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase
por: Khan, Suliman, et al.
Publicado: (2021) -
Assessment of nucleotide/nucleoside analog intervention in primer-dependent viral RNA-dependent RNA polymerases
por: Liu, Qiaojie, et al.
Publicado: (2022) -
Molecular mechanism for conformational activation of SARS-CoV-2 RNA polymerase by nucleoside triphosphate
por: Ma, Wen, et al.
Publicado: (2022) -
Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
por: Zandi, Keivan, et al.
Publicado: (2021)